Skip to main content
logo
Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.200
-0.005 (-0.23%)
Oct 9, 2026, 9:42 AM HKT

Wuhan YZY Biopharma Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4851,5551,6051,725--
Market Cap Growth
-63.18%-3.14%-6.97%---
Enterprise Value
5571,5441,5601,665--
Last Close Price
2.508.028.288.90--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.2020.9013.99---
PB Ratio
-7.17-26.3449.4012.27--
P/TBV Ratio
--49.4012.27--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
8.2820.7613.60---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-2.37-2.414.170.710.490.20
Net Debt / Equity Ratio
-1.07-0.520.04-0.83-0.59-0.40
Net Debt / EBITDA Ratio
-2.75-0.36-0.010.670.540.46
Net Debt / FCF Ratio
-0.94-1.23-0.010.570.520.57
Asset Turnover
0.280.300.38-0.01-
Inventory Turnover
11.3814.884.54---
Quick Ratio
0.500.570.991.221.151.50
Current Ratio
0.550.661.191.441.632.21
Return on Equity (ROE)
---123.40%-135.22%-126.31%-
Return on Assets (ROA)
-7.87%-22.74%-21.51%-34.20%-43.63%-
Return on Capital Employed (ROCE)
44.80%315.60%-119.90%-129.40%-112.60%-92.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.66%-6.07%-6.47%-12.24%--
FCF Yield
-15.84%-1.61%-6.78%-12.00%--
Buyback Yield / Dilution
---4.72%-7.60%-13.10%-